Compare GPCR & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPCR | ENPH |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Semiconductors |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.8B |
| IPO Year | 2023 | 2011 |
| Metric | GPCR | ENPH |
|---|---|---|
| Price | $63.38 | $42.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 25 |
| Target Price | ★ $104.64 | $43.48 |
| AVG Volume (30 Days) | 778.2K | ★ 7.5M |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.00 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $1,472,985,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.78 |
| P/E Ratio | ★ N/A | $33.02 |
| Revenue Growth | N/A | ★ 10.72 |
| 52 Week Low | $13.24 | $25.78 |
| 52 Week High | $94.90 | $66.70 |
| Indicator | GPCR | ENPH |
|---|---|---|
| Relative Strength Index (RSI) | 32.83 | 48.55 |
| Support Level | $60.42 | $34.38 |
| Resistance Level | $72.00 | $43.25 |
| Average True Range (ATR) | 3.33 | 2.90 |
| MACD | -1.01 | -0.87 |
| Stochastic Oscillator | 18.38 | 20.06 |
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.